This inhibition can lead to excess cortisol, which stimulates mineralocorticoid receptors and results in symptoms similar to hyperaldosteronism, such as increased sodium retention, potassium loss, and high blood pressure. This evidence concerns the gene NR3C2 and hypertensive disorder.